Find the biology your trial wasn't looking for.
Your trial measured the endpoints you pre-defined — but the data holds far more. Discovery explores it all, surfaces the populations you missed, and feeds new biomarkers back into your next study.
Your trial only measured what you knew to ask.
Pre-defined endpoints answer the question you set out with — but the most important biology is often the part you didn't anticipate.
You measured a slice
Endpoints capture pre-specified readouts. Everything else in the sample goes unexamined.
The signal hides in the rest
Rare and unexpected populations — often the ones that explain response — never surface under a fixed gating template.
Insight comes too late
By the time you'd re-analyze by hand, the trial is closed and the next one is already designed.
Unbiased exploration of every population in your data.
No gating template, no prior hypothesis. Discovery annotates every robust population in the sample — so the biology you didn't predict can finally show up.
Every population, annotated
AI-driven annotation across the full sample — not just the gates you drew.
Rare & novel phenotypes
Surfaces the low-frequency populations a manual template was never designed to see.
Unbiased by design
Hypothesis-free exploration removes the assumptions baked into manual gating.
Feeds back into Endpoints
Promote what you find into pre-defined endpoints for your next trial.
On clean, analyzed data
Includes Resolve and Endpoints, so unmixing and analysis are handled underneath.
Days, not months
Explore the full depth of a study without a manual re-analysis project.
Each trial makes the next one sharper.
Discovery turns a finished study into the starting point for a better one.
Run the trial
Collect samples and measure your pre-defined biomarker endpoints.
Endpoints
Automated, reproducible readouts on the questions you set out with.
Discovery
Explore everything you didn't pre-specify — surface what you missed.
Next trial
Promote new biomarkers into Endpoints and stratify the next study.
What teams have found with Discovery.
Predicting immunotherapy response
In Merkel cell carcinoma and melanoma — phenotypes linked to response, benchmarked against conventional analysis.
View case study →A suppressive T-cell population
Discovery surfaced a population in the tumor microenvironment that dampens immune response — informing IO drug development.
View case study →Structure missed in published data
Re-analysis of a published COVID-19 dataset surfaced populations the original manual workflow didn't capture.
View case study →The top tier — it includes everything below.
Discovery builds on Endpoints and Resolve, on one data model. Your unmixing and endpoint analysis are already handled — Discovery adds unbiased, full-depth exploration on top.
Discovery
Biomarker discovery & exploration
Endpoints
Automated trial biomarker analysis
Resolve
Adaptive spectral unmixing
Explore it yourself, or have us run it.
Your team explores
Run Discovery on your own data — buy a license and pay only for the files you process. We onboard and train your team.
- ✓ Includes Resolve + Endpoints
- ✓ License + pay-per-file
- ✓ Onboarding & training included
We deliver the findings
Our scientists run the exploration end to end and deliver the populations and biomarkers worth carrying into your next trial.
- ✓ Expert-led exploration
- ✓ Optional data generation by the Lab
- ✓ Delivered under a validated quality system
Find what your last trial missed.
Bring a finished study — we'll show you what unbiased exploration surfaces.